Replication of a genome-wide case-control study of esophageal squamous cell carcinoma

International Journal of Cancer

Volumn 123, Issue 7, 2008, Pages 1610-1615

  Ng, David ^a   Hu, Nan ^a   Hu, Ying ^a   Wang, Chaoyu ^a   Giffen, Carol ^b   Tang, Ze Zhong ^c   Han, Xiao You ^c   Yang, Howard H ^a   Lee, Maxwell P ^a   Goldstein, Alisa M ^a   Taylor, Philip R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c SHANXI CANCER HOSPITAL   (China)

Author keywords

Esophageal cancer; Replication study; SNP

Indexed keywords

ADULT; AGED; ARTICLE; CHINA; CONTROLLED STUDY; EPHB1 GENE; ESOPHAGUS CARCINOMA; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC ASSOCIATION; GENOME ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PGLYRP2 GENE; PIK3C3 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SLC9A9 GENE; SQUAMOUS CELL CARCINOMA; ALLELE; CASE CONTROL STUDY; ESOPHAGUS TUMOR; GENETICS; GENOME; LIFESTYLE; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; ALLELES; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GENOME, HUMAN; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 50549101277     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23682     Document Type: Article

References (27)

1. Li JY. Epidemiology of esophageal cancer in China. Natl Cancer Inst Monogr 1982;62:113-20.
2. National Cancer Control Office. Investigation of cancer mortality in China. Beijing: People's Health Publishing House; 1980.
3. Hu N, Dawsey SM, Wu M, Taylor PR. Family history of oesophageal cancer in Shanxi Province, China. Eur J Cancer 1991;27:1336.
4. Hu N, Dawsey SM, Wu M, Bonney GE, He LJ, Han XY, Fu M, Taylor PR. Familial aggregation of oesophageal cancer in Yangcheng County, Shanxi Province, China. Im J Epidemiol 1992;21:877-82.
5. Mark SD, Qiao YL, Dawsey SM, Wu YP, Katki H, Gunter EW, Fraumeni JF, Jr, Blot WJ, Dong ZW, Taylor PR. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 2000;92:1753-63.
6. Taylor PR, Qiao YL, Abnet CC, Dawsey SM, Yang CS, Gunter EW, Wang W, Bot WJ, Dong ZW, Mark SD. Prospective study of serum vitamin E levels and esophageal and gastric cancers. J Natl Cancer Inst 2003;95:1414-6.
7. Abnet CC, Qiao YL, Mark SD, Dong ZW, Taylor PR, Dawsey SM. Prospective study of tooth loss and incident esophageal and gastric cancers in China. Cancer Causes Control 2001;12:847-54.
8. Carter CL, Hu N, Wu M, Lin PZ, Murigande C, Bonney GE. Segregation analysis of esophageal cancer in 221 high-risk Chinese families. J Natl Cancer Inst 1992;84:771-6.
9. Hu N, Wang C, Hu Y, Yang HH, Giffen C, Tang ZZ, Han XY, Goldstein AM, Emmert-Buck MR, Buetow KH, Taylor PR, Lee MP. Genome-wide association study in esophageal cancer using the genechip mapping 10K array. Cancer Res 2005;65:2542-6.
10. Landegren U, Kaiser R, Sanders J, Hood L. A ligase-mediated gene detection technique. Science 1988;241:1077-80.
11. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005;37:1217-23.
12. Poliakov A, Cotrina M, Wilkinson DG. Diverse roles of Eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev Cell 2004;7:465-80.
13. Katoh M, Katoh M. Comparative intergromics on Eph family. Int J Oncol 2006;28:1243-7.
14. Batlle E, Bacani J, Begthel H, Jonkheer S, Gregorieff A, Van de Born M, Malats N, Sancho E, Boon E, Pawson T, Gallinger S, Pals S, Clevers H. EphB receptor activity suppresses colorectal cancer progression. Nature 2005;435:1126-30.
15. Kojima T, Chang JH, Azar DT. Proangiogenic role of ephrinB1/EphB1 in basic fibroblast growth factor-induced corneal angiogenesis. Am J Pathol 2007;170:764-73.
16. Liu C, Xu Z, Gupta D, Dziarski R. Peptidoglycan recognition proteins: a novel family of four human innate immunity pattern recognition molecules. J Biol Chem 2001;276:34686-94.
17. Wang ZM, Li X, Cocklin RR, Wang M, Wang M, Fukase K, Inamura S, Kusumoto S, Gupta D, Dziarski R. Human peptidoglycan protein-L is an N-acetylmuramoyl-1-alanine amidase. J Biol Chem 2003;278:49044-52.
18. Xi L, Wang S, Wang H, Gupta D. Differential expression of peptidoglycan recognition protein 2 in the skin and liver requires different transcription factors. J Biol Chem 2006;281:20738-48.
19. Bertucci F, Salas S, Eysteries S, Nasser V, Finetti P, Ginestier C, Charafe-Jauffret E, Loriod B, Bachelart L, Montfort J, Victorero G, Viret F, el al. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 2004;23:1377-91.
20. Yamada S, Ohira M, Horie H, Ando K, Takayasu H, Suzuki Y, Sugano S, Hirata T, Goto T, Matsunaga T, Hiyama E, Hayashi Y, et al. Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas. Oncogene 2004;23:5901-11.
21. Volinia S, Dhand R, Vanhaesebroeck B, MacDougall LK, Stein R, Zvelebil MJ, Domin J, Panaretou C, Waterfield MD. A human phosphatidylinositol 3-kinase complex related to the yeast Vps34p-Vps15p protein sorting system. EMBO J 1995;14:3339-48.
22. Carter CJ. Multiple genes and factors associated with bipolar disorder converge on growth factor and stress activated kinase pathways controlling translation initiation: implications for oligodendrocyte viability. Neurochem Int 2007;50:461-90.
23. Toker A, Yoeli-Lerner M. Akt signaling and cancer: surviving but not moving on. Cancer Res 2006;66:3963-6.
24. Gandemer V, Rio AG, de Tayrac M, Sibut V, Mottier S, Ly Sunnaram B, Henry C, Monnier A, Berthou C, Le Gall E, Le Treut A, Schmitt C, et al. Five distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-positive leukemia. BMC Genomics 2007;8:385-99.
25. Orlowski J, Grinstein S. Diversity of the mammalian sodium/proton exchanger SLC9 gene family. Pflugers Ach 2004;447:549-65.
26. + antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin-one single nature. Biochim Biophys Acta 2005;1756:1-24.
27. Tamura K, Furihata M, Tsunoda T, Ashida S, Takata R, Obara W, Yoshioka H, Daigo Y, Nasu Y, Kumon H, Konaka H, Namiki M, et al. Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles. Cancer Res 2007;67:5117-25.